SCHEMBL465383

SCHEMBL465383

CCCC(CN(O)O)N(O)O

nearest known ligand 0.31

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HDAC7 Q8WUI4 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6544044 0.78
SCHEMBL465472 0.78
SCHEMBL465343 0.73
SCHEMBL2839300 0.70 LMNA (0.44) TSHR
SCHEMBL24773119 0.69 TSHR (0.35) TSHR
SCHEMBL9930065 0.67 TSHR (0.33) TSHR
SCHEMBL7528495 0.67
SCHEMBL10660488 0.66 TSHR (0.35) TSHR
SCHEMBL17866356 0.65 SLC6A4 (0.37)
SCHEMBL19937888 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4143009-A POLYURETHANE-EPOXY CASTING RESIN DEWEY FRANK 1979-03-06 US claimed
US-10660969-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2020-05-26 US disclosed
US-10434182-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2019-10-08 US disclosed
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2018-08-02 US disclosed
EP-3315531-A1 8-ARM POLYETHYLENE GLYCOL DERIVATIVE, MANUFACTURING METHOD AND MODIFIED BIO-RELATED SUBSTANCE THEREBY Xiamen Sinopeg Biotech Co., Ltd. (CN) 2018-05-02 EP disclosed
US-8481652-B2 Thermoplastic polyamides having polyether amines BASF SE (DE) 2013-07-09 US disclosed
WO-2012007301-A3 FOAM ENHANCEMENT OF FATTY ACYL GLYCINATE SURFACTANTS UNILEVER PLC (GB) 2012-05-10 WO disclosed
EP-2257597-B1 POLYAMIDE NANOCOMPOSITES WITH HYPER- BRANCHED POLYETHERAMINES BASF SE (DE) 2011-11-30 EP disclosed
EP-2227507-B1 THERMOPLASTIC POLYAMIDES HAVING POLYETHER AMINES BASF SE (DE) 2011-08-31 EP disclosed
US-20110021687-A1 POLYAMIDE NANOCOMPOSITES WITH HYPER-BRANCHED POLYETHYLENEIMINES BASF SE (DE) 2011-01-27 US disclosed
WO-2009115535-A2 POLYAMIDE NANOCOMPOSITES WITH HYPER- BRANCHED POLYETHERAMINES BASF SE (DE) 2009-09-24 WO disclosed
WO-2009115536-A1 POLYAMIDE NANOCOMPOSITES WITH HYPER-BRANCHED POLYETHYLENIMINES BASF SE (DE) 2009-09-24 WO disclosed
WO-2009077492-A2 THERMOPLASTIC POLYAMIDES HAVING POLYETHER AMINES BASF SE (DE) 2009-06-25 WO disclosed
WO-2009050094-A1 THERMOPLASTIC POLYESTER MOLDING COMPOUNDS COMPRISING HIGHLY BRANCHED POLYETHER AMINES BASF SE (DE) 2009-04-23 WO disclosed
EP-0603716-A1 Fast-curing, high strength, two-part sealants using acetoacetate-amine cure chemistry TREMCO INCORPORATED (US) 1994-06-29 EP disclosed
US-4239700-A Isatoic anhydride derivatives and use as chain-extenders TEXACO DEVELOPMENT CORP. (US) 1980-12-16 US disclosed
US-4194070-A Isatoic anhydride derivatives and use as chain-extenders TEXACO DEVELOPMENT CORPORATION (US) 1980-03-18 US disclosed
US-4191706-A REACTION PRODUCT OF POLYOXYPROPYLENEPOLYAMINE AND ISATOIC ANHYDRIDE TEXACO DEVELOPMENT CORP. (US) 1980-03-04 US disclosed
US-4180644-A Polyurethane chain-extenders TEXACO DEVELOPMENT CORP. (US) 1979-12-25 US disclosed
US-4143009-A POLYURETHANE-EPOXY CASTING RESIN DEWEY FRANK 1979-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10434182-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof MRPL38, ALG8, MRPS18A HDAC7 2253/4885HDAC8 990/4885HDAC6 3929/4885
US-10660969-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof MRPL38, ALG8, COG8 HDAC7 2773/4885HDAC8 1248/4885HDAC6 4307/4885
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF MRPL38, CXCL8, ALG8 HDAC7 1873/4885HDAC8 869/4885HDAC6 3518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.